Additional level of information about complex interaction between non-nucleoside inhibitor and HIV-1 reverse transcriptase using biosensor-based thermodynamic analysis

Bioorganic & Medicinal Chemistry
2007.0

Abstract

The thermodynamics of the interaction between mutant HIV-1 reverse transcriptase (K103N and Y181C) and a non-nucleoside reverse transcriptase inhibitor (NNRTI), the phenylethylthiazolylurea compound MIV-150, was obtained by determining the temperature dependence of the kinetic rate constants. Large entropic changes in the forward and backward steps of the isomerization between a non-binding competent and a binding competent conformation of the enzyme, as well as in the binding steps, implied the involvement of major structural rearrangements upon interaction with the inhibitor. Despite of the entropic character of the overall interaction, the equilibrium for the binding of inhibitor was found to be predominantly enthalpy-driven. The high affinity and the low affinity interactions of the heterogeneously interacting inhibitor showed different energetics in the analysis, revealing an expectedly higher enthalpic component for the high-affinity interaction. The thermodynamic profiles of the two enzyme variants displayed significant differences, which could not be derived from their kinetics at a single temperature.

Knowledge Graph

Similar Paper

Additional level of information about complex interaction between non-nucleoside inhibitor and HIV-1 reverse transcriptase using biosensor-based thermodynamic analysis
Bioorganic & Medicinal Chemistry 2007.0
Molecular Modeling Calculations of HIV-1 Reverse Transcriptase Nonnucleoside Inhibitors:  Correlation of Binding Energy with Biological Activity for Novel 2-Aryl-Substituted Benzimidazole Analogues
Journal of Medicinal Chemistry 2003.0
Estimation of Binding Affinities for HEPT and Nevirapine Analogues with HIV-1 Reverse Transcriptase via Monte Carlo Simulations
Journal of Medicinal Chemistry 2001.0
Threshold interaction energy of NRTI's (2$prime;-deoxy 3$prime;-substituted nucleosidic analogs of reverse transcriptase inhibitors) to undergo competitive inhibition
Bioorganic & Medicinal Chemistry Letters 2004.0
Urea−PETT Compounds as a New Class of HIV-1 Reverse Transcriptase Inhibitors. 3. Synthesis and Further Structure−Activity Relationship Studies of PETT Analogues
Journal of Medicinal Chemistry 1999.0
N1-Heterocyclic pyrimidinediones as non-nucleoside inhibitors of HIV-1 reverse transcriptase
Bioorganic & Medicinal Chemistry Letters 2010.0
Rational Design of Potent Non-Nucleoside Inhibitors of HIV-1 Reverse Transcriptase
Journal of Medicinal Chemistry 2012.0
Relationships between Structure and Interaction Kinetics for HIV-1 Protease Inhibitors
Journal of Medicinal Chemistry 2002.0
Picomolar Inhibitors of HIV-1 Reverse Transcriptase: Design and Crystallography of Naphthyl Phenyl Ethers
ACS Medicinal Chemistry Letters 2014.0
Improved Structure−Activity Relationship Analysis of HIV-1 Protease Inhibitors Using Interaction Kinetic Data
Journal of Medicinal Chemistry 2004.0